Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birthe Gericke

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Neuropharmacology|October 27, 2019
Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse modelBirthe Gericke, Claudia Brandt, Wiebke Theilmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2018
Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophilsAndreas Noack, Birthe Gericke, Maren von Köckritz-Blickwede, et al.
Neurobiology of Disease|February 13, 2021
Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsyPhilip Hampel, Marie Johne, Björn Gailus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2023
Double-Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α-SynucleinAlina Schidlitzki, Milos Stanojlovic, Céline Fournier, et al.
Glycobiology|February 11, 2020
A mutation map for human glycoside hydrolase genesLars Hansen, Diab M Husein, Birthe Gericke, et al.
Neuropharmacology|September 5, 2020
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complexWiebke Theilmann, Birthe Gericke, Alina Schidlitzki, et al.
Neurobiology of Disease|November 4, 2019
Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsyAlina Schidlitzki, Pablo Bascuñana, Prashant K Srivastava, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Neuropharmacology|October 27, 2019
Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse modelBirthe Gericke, Claudia Brandt, Wiebke Theilmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2018
Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophilsAndreas Noack, Birthe Gericke, Maren von Köckritz-Blickwede, et al.
Neurobiology of Disease|February 13, 2021
Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsyPhilip Hampel, Marie Johne, Björn Gailus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2023
Double-Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α-SynucleinAlina Schidlitzki, Milos Stanojlovic, Céline Fournier, et al.
Glycobiology|February 11, 2020
A mutation map for human glycoside hydrolase genesLars Hansen, Diab M Husein, Birthe Gericke, et al.
Neuropharmacology|September 5, 2020
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complexWiebke Theilmann, Birthe Gericke, Alina Schidlitzki, et al.
Neurobiology of Disease|November 4, 2019
Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsyAlina Schidlitzki, Pablo Bascuñana, Prashant K Srivastava, et al.
Pageof 3